Targeting nonclassical oncogenes for therapy in T-ALL.

Subramaniam PS, Whye DW, Efimenko E, Chen J, Tosello V, De Keersmaecker K, Kashishian A, Thompson MA, Castillo M, Cordon-Cardo C, Davé UP, Ferrando A, Lannutti BJ, Diacovo TG
Cancer Cell. 2012 21 (4): 459-72

PMID: 22516257 · DOI:10.1016/j.ccr.2012.02.029

MeSH Terms (20)

Animals Antineoplastic Agents Apoptosis Binding Sites Cell Line, Tumor Cell Proliferation Cell Transformation, Neoplastic Class Ib Phosphatidylinositol 3-Kinase Class I Phosphatidylinositol 3-Kinases Drug Design Gene Silencing Humans Mice Phosphatidylinositol 3-Kinases Phosphoinositide-3 Kinase Inhibitors Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Protein Isoforms PTEN Phosphohydrolase Purines Quinazolinones

Connections (2)

This publication is referenced by other Labnodes entities:

Links